LV-CMV-iCre-Puro

Price: $468.00

Add to Cart:

  • Catalog #: SL100296
  • Unit Size: 2 x 25 µL (>10^9 TU/mL)

Please Choose:



LV-CMV-iCre-Puro; LV-CMV-iCre; CMV-iCre-Puro Lentivirus; CMV-iCre Lentivirus

Product Category: Pre-made recombinant lentivirus; LV-CMV-iCre-Puro; LV-CMV-iCre; CMV-iCre-Puro Lentivirus; CMV-iCre Lentivirus

Description: Cre recombinase is a type I topoisomerase from bacteriophage P1 that catalyzes the site-specific recombination of DNA between loxP sites.  Cre recombinase is used as a tool to genetically modify genes, such as to delete a segment of DNA flanked by LoxP sites in cells or experimental animals.  By optimizing the mammalian codon usage for Cre recombinase, Cre expression is improved in the mammalian cells. This codon-improved Cre (known as iCre) transgene shows lower CpG content from the prokaryotic coding sequence, thus reducing the chances of epigenetic silencing in mammals.

This L
V-CMV-iCre-Puro pre-made lentivirus expresses iCre recombinase under CMV promoter with co-expression of puromycin selection under PGK promoter.  Ready to use format.

Titer: > 1x109 TU/mL

Selection Antibiotic: Puromycin


Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection

Size: 2 x 25 µL (Std Pack)

Storage Buffer: PBS

Infection Protocol:


Transfer Vector Map:
LV-CMV-iCre-Puro; LV-CMV-iCre; CMV-iCre-Puro Lentivirus; CMV-iCre Lentivirus


*
Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm



Customers who bought this product also purchased...



Copyright © 2017 SignaGen Laboratories. All Rights Reserved.